ClearPoint Neuro, Inc.
CLPT
$12.97
-$0.14-1.07%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 12.83% | 19.68% | 23.22% | 31.04% | 36.34% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 12.83% | 19.68% | 23.22% | 31.04% | 36.34% |
| Cost of Revenue | 10.17% | 17.98% | 11.43% | 18.63% | 28.91% |
| Gross Profit | 14.57% | 20.82% | 32.08% | 40.46% | 41.69% |
| SG&A Expenses | 16.95% | 18.48% | 14.88% | 8.55% | 9.80% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 15.89% | 20.57% | 14.38% | 10.11% | 10.57% |
| Operating Income | -20.84% | -21.91% | -3.34% | 12.22% | 15.33% |
| Income Before Tax | -27.54% | -23.47% | -0.66% | 14.57% | 17.17% |
| Income Tax Expenses | 15.91% | 90.00% | 213.33% | -- | -- |
| Earnings from Continuing Operations | -27.51% | -23.58% | -0.81% | 14.37% | 16.97% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -27.51% | -23.58% | -0.81% | 14.37% | 16.97% |
| EBIT | -20.84% | -21.91% | -3.34% | 12.22% | 15.33% |
| EBITDA | -22.58% | -21.87% | -2.96% | 14.20% | 17.77% |
| EPS Basic | -19.54% | -13.21% | 9.51% | 22.16% | 22.23% |
| Normalized Basic EPS | -19.56% | -13.12% | 9.62% | 22.33% | 22.41% |
| EPS Diluted | -19.54% | -13.21% | 9.51% | 22.16% | 22.23% |
| Normalized Diluted EPS | -19.56% | -13.12% | 9.62% | 22.33% | 22.41% |
| Average Basic Shares Outstanding | 6.52% | 8.79% | 11.16% | 9.84% | 6.90% |
| Average Diluted Shares Outstanding | 6.52% | 8.79% | 11.16% | 9.84% | 6.90% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |